| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.87B | 18.64B | 15.81B | 16.38B | 16.13B | 14.00B |
| Gross Profit | 2.24B | 2.07B | 1.90B | 2.44B | 2.93B | 2.50B |
| EBITDA | 2.18B | 2.38B | 839.00M | 2.08B | 2.36B | 2.05B |
| Net Income | 858.00M | 820.00M | -1.00B | 922.00M | 1.58B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 25.24B | 24.33B | 24.98B | 24.70B | 21.54B | 18.82B |
| Cash, Cash Equivalents and Short-Term Investments | 2.75B | 2.77B | 2.25B | 2.39B | 3.42B | 3.25B |
| Total Debt | 5.53B | 5.45B | 6.35B | 4.72B | 3.99B | 3.28B |
| Total Liabilities | 10.11B | 9.47B | 10.45B | 9.52B | 7.25B | 6.07B |
| Stockholders Equity | 15.12B | 14.86B | 14.54B | 15.17B | 14.28B | 12.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.86B | -1.71B | -1.59B | -342.00M | 2.14B |
| Operating Cash Flow | 0.00 | 2.75B | 1.05B | 404.00M | 1.15B | 2.53B |
| Investing Cash Flow | 0.00 | -1.19B | -2.67B | -2.00B | -1.52B | -376.00M |
| Financing Cash Flow | 0.00 | -1.03B | 1.48B | 563.00M | 543.00M | -281.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥13.98B | 11.09 | ― | 3.89% | -3.00% | -29.83% | |
78 Outperform | ¥42.87B | 8.34 | ― | 3.53% | -3.45% | 30.52% | |
71 Outperform | ¥14.75B | 17.06 | ― | 1.81% | 9.07% | ― | |
68 Neutral | ¥15.63B | -46.01 | ― | ― | -16.76% | 74.95% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥11.01B | 84.19 | ― | 1.06% | -9.63% | -1.71% | |
48 Neutral | ¥13.27B | -10.19 | -7.76% | ― | -19.70% | -159.15% |